Associations of body fat and inflammation with non-communicable chronic diseases and mortality: A prospective cohort study

IntroductionCertain leading medical organizations are considering alternatives to the body mass index (BMI) as a predictor of the risk for non-communicable chronic disease (NCD) or death. Our objective was to evaluate the associations between various measures of body fat and the risk of incident NCDs or mortality, independent of inflammation. MethodsThis was a population-based prospective cohort study (the UK Biobank cohort) set in the United Kingdom. The participants (between 40 and 69 years) accrued between March 2006 and October 2010, and followed until December 2022. The exposures were BMI, waist:hip ratio (WHR), bioimpedance analysis-measured body fat (fatBIA), C-reactive protein (CRP) and various other measures of body fat obtained by dual-energy X-ray absorptiometry (including visceral adipose tissue) and magnetic resonance imaging. The outcomes were all-cause death, cardiovascular disease (heart failure, hypertension, myocardial infarction, pulmonary embolism, and stroke), cancers (breast, colorectal, endometrial, esophageal, kidney, ovarian, pancreatic, and prostate), diabetes, asthma, gallbladder disease, chronic back pain, and osteoarthritis. ResultsThere were 500,107 participants: the median age was 58 years (interquartile range 50-63) at baseline and 45.6% were male. The 5th and 95th%iles for measures of body fat were: BMI 20.5 (considered "healthy") and 37.0 kg/m2 (considered "unhealthy"), WHR 0.71 and 0.94, BIA 24.8 and 47.6% in females, and in males BMI 22.0 (considered "healthy") and 35.4 kg/m2 (considered "unhealthy"), WHR 0.83 and 1.05, BIA 15.5 and 34.7%. BMI was strongly correlated to fatBIA (0.85 in females, 0.80 in males) but less so with WHR (0.46 in females, 0.59 in males). All measures of body fat were positively associated with the incidence of NCDs but only WHR remained positively associated with death after full adjustment (HR 95th%ile vs 5th%ile [95%CI]: BMI 0.80 [0.76,0.84], WHR 1.21 [1.16,1.28], BIA 0.80 [0.76,0.84] in females; BMI 0.89 [0.85,0.93], WHR 1.19 [1.14,1.24], BIA 0.89 [0.85,0.92] in males). Simpler models that adjusted for age, sex, CRP, WHR and either BMI or fatBIA gave similar results. Associations between body fat and the incidence of NCDs after accounting for the competing risk of death were also similar. ConclusionBMI was strongly correlated with fatBIA, but WHR and VATDXA were less so. All measures of body fat were associated with the incidence of NCDs but only WHR was independently associated with mortality. These findings support the hypothesis that body fat may be protective against death, and that the excess risk associated with higher WHR may be mediated by something other than body fat. Key QuestionsO_ST_ABSWhat is already known about this topic?C_ST_ABSO_LIObesity as measured by body mass index is associated with chronic disease but less so with mortality. C_LIO_LILess is known about alternative measures of body fat. C_LI What this study adds?O_LIBody mass index is strongly correlated with body fat as measured by bioimpedance analysis, but less so with the waist:hip ratio and visceral adipose tissue. C_LIO_LIAll measures of body fat were associated with the incidence of chronic disease but only the waist:hip ratio was independently associated with mortality. C_LI How this study might affect research, practice or policy?O_LIThese findings support the hypothesis that body fat may be protective against death, and that the excess risk associated with higher waist:hip ratio may be mediated by something other than body fat. C_LI